Home » Topics » BioWorld Science

BioWorld Science
RSS

New agents for atherosclerosis from Bayer

May 30, 1997

Antifibrotic agents claimed by Hoechst

May 30, 1997

Yamanouchi discloses Na+/H+ exchange inhibitors

May 30, 1997

Daiichi reports compounds for RA, allergy and transplant rejection

May 30, 1997

Antiemetics described by Dainippon

May 30, 1997

Eisai develops agents for brain cancer

May 30, 1997

Inhibitors of IL-1beta/IL-6 production from Taisho

May 30, 1997

Biomira notified of patent allowance for Theratope

May 30, 1997

Meridian receives approval to market its E. coli detection kit in Japan

May 30, 1997

Monarch acquires ocular therapy from Glaxo Wellcome

May 30, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...